GEMMA Biotherapeutics
GEMMA Biotherapeutics is a therapeutics company focused on advancing research and global access to life-changing advanced therapies for those living with rare diseases. The company aims to accelerate the development and delivery of gene therapies from research to patient treatment in a faster and more affordable manner. They are led by gene therapy pioneer Jim Wilson and his team of experts.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $34M
Date: 23-Dec-2024
Investors: Double Point Ventures, Bioluminescence Ventures, Earlybird Venture Capital, Savanne Life Sciences
Markets: Gene Therapy, Rare Disease, Quality Assurance, GXP operations, Regulatory affairs, Clinical development, Discovery research, Translational research, Vector research, Biomedical research, Orphan disease, Genetic disease, Genetic medicine, AAV vectors, Bioinformatics, Capsid engineering, and Genome editing
HQ: Philadelphia, Pennsylvania, United States
Founded: 2024
Website: https://www.gemmabiotx.com/
Leave a Comment
Comments
No comments yet.